Q3 2014 13F Holders as of 30 Sep 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44,666,667
-
Number of holders
-
69
-
Total 13F shares, excl. options
-
18,114,180
-
Shares change
-
+409,352
-
Total reported value, excl. options
-
$74,082,911
-
Value change
-
+$1,290,910
-
Number of buys
-
31
-
Number of sells
-
-35
-
Price
-
$4.09
Significant Holders of HARVARD BIOSCIENCE INC - Common Stock (HBIO) as of Q3 2014
83 filings reported holding HBIO - HARVARD BIOSCIENCE INC - Common Stock as of Q3 2014.
HARVARD BIOSCIENCE INC - Common Stock (HBIO) has 69 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18,114,180 shares
of 44,666,667 outstanding shares and own 41% of the company stock.
Largest 10 shareholders include GRANAHAN INVESTMENT MANAGEMENT INC/MA (1,644,590 shares), DIMENSIONAL FUND ADVISORS LP (1,507,579 shares), BlackRock Institutional Trust Company, N.A. (1,293,843 shares), First Light Asset Management, LLC (1,063,840 shares), JUPITER ASSET MANAGEMENT LTD (1,003,819 shares), BANK OF MONTREAL /CAN/ (1,001,830 shares), VANGUARD GROUP INC (997,425 shares), HUSSMAN STRATEGIC ADVISORS, INC. (930,000 shares), ACADIAN ASSET MANAGEMENT LLC (871,829 shares), and ROYCE & ASSOCIATES LLC (774,800 shares).
This table shows the top 69 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.